Invesco S&P 500 Equal Weight Health Care ETF

CVS Health Reaffirms Commitment to Military Community, Plans $292M Investment in 2025

Deutsche Bank Cuts Cigna Group Price Target to $302 from $303

Trump Portfolio Precisely Trades UnitedHealth Before Medicare Policy Reversal

Gamco Investors Reduces CVS Health Stake by 11.6% and Sells Nearly 15,000 Shares

UnitedHealth Group Faces Profit Pressure Amid Rising Medical Costs and Membership Structure Changes

Humana Secures $1.5 Billion Financing Agreement to Issue Senior Notes

Zacks Raises UnitedHealth's Q1 2027 EPS Estimate to $6.87

Multiple Institutional Investors Disclose Increased Stakes in UnitedHealth Group on May 19, 2026

Barclays Offers Structured Notes Linked to UnitedHealth Group Stock

Wells Fargo Raises UnitedHealth Group's Price Target to $397

DaVita Sets 2030 ESG Goals: Focusing on Patient Transplants, Workforce Development, and 100% Renewable Energy

Judge grants Luigi Mangione's request to suppress evidence in UnitedHealth CEO murder case

UnitedHealth Group will hold its Annual General Meeting on June 2, 2026

FDA Accepts Viatris Meloxicam NDA, PDUFA Date Set for Dec 2026

North Dakota Investment Board Increases CVS Holdings as Q1 Earnings Beat Expectations

Berkshire Hathaway exited its entire position in UnitedHealth Group during the first quarter, causing the stock to slide 4% overnight.

CVS Health Joins CNCF as Platinum Member to Optimize Tech Architecture

UnitedHealthcare's D.C. Community Plan Earns NCQA Distinction for Long-Term Services and Supports

UnitedHealth's Optum Rx Introduces New Pharmacy Care Model for Transparency

UnitedHealth Group to Host UHC Medicare Sales Virtual Job Fair

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

MetaVia

Vida Global

BiomX

Micware

Tradr 2X Long XNDU Daily ETF

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HIMS

HIMY

RSPH

This week, Wall Street saw declines, particularly in technology stocks, while the S&P 500 Health Care Index gained 1.09%. Notable healthcare news includes UnitedHealth's new pharmacy pricing model set for 2027, a $15.2B licensing deal between Bristol Myers Squibb and Hengrui Pharma, and Hims & Hers Health reporting disappointing Q1 results. Additionally, concerns were raised about the potential impact of Trump's drug policy on US biopharma innovation.

businessinsider

Bristol Myers Squibb

Hims & Hers Health

Defiance Leveraged Long +Income HIMS ETF

Direxion Pharma & Medical Bull 3X

iShares Biotechnology ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

Defiance Daily Target 2X Long HIMS ETF

VanEck Biotech ETF

iShares US Medical Devices

iShares Global Healthcare

VG Health

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

Invesco Nasdaq Biotechnology ETF

ProShares Ultra Health Care ETF

SPDR S&P Health Equip

iShares US Healthcare Providers

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus

CURE

Molina Healthcare shareholders approved governance and bylaw changes at the May 6, 2026 annual meeting. Key amendments allow stockholders with at least 20% voting power to call special meetings. The board adopted new bylaws detailing procedural safeguards. Shareholders elected ten directors, ratified Ernst & Young as auditor, and increased shares under the 2025 Equity Incentive Plan. The latest analyst rating for MOH stock is a Buy with a $250 price target, though concerns about recent fundamentals and valuation persist. Molina Healthcare focuses on providing health insurance to low-income populations.

Tip Ranks

Molina Healthcare

Direxion Healthcare Bull 3X

SPDR S&P Health

Molina Healthcare Shareholders Approve Governance and Bylaw Changes

Centric Wealth Management has reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 74.3%, now holding 3,100 shares valued at $562,000. Other institutional investors have also adjusted their positions in the company. Molina Healthcare's stock opened at $186.07, with a market cap of $9.69 billion and a PE ratio of 55.05. Analysts have mixed ratings on the stock, with a consensus rating of "Hold" and an average price target of $169.60. The company specializes in government-sponsored health insurance programs.

Market Beat

Rakuten Group, Inc.

Centene

Mizuho Financial Group, Inc.

Mizuho Financial

Deutsche Bank AG

Goldman Sachs

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

GS Hldg R

Centric Wealth Management Cuts Stock Position in Molina Healthcare, Inc $MOH

Wall Street's major indices rose on Friday, with the S&P 500 Health Care Index slipping 1.15% for the week. Notable healthcare news includes UnitedHealthcare's plan to cut prior authorization requirements by 30%, Pfizer's Q1 results exceeding estimates, and Amazon's launch of Novo Nordisk's Ozempic pill for same-day delivery. CVS Health shares surged over 7% after raising its full-year outlook, while Angelini Pharma announced its acquisition of Catalyst Pharmaceuticals for $4.1B. The healthcare sector remains dynamic amid these developments.

Pfizer

CVS Health

Unitedhealth

iShares US Pharma

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus

Molina Healthcare Inc. (MOH) shares fell 1.72% to $192.17 on Tuesday, underperforming against competitors despite a positive market day, with the S&P 500 up 0.81%. The stock is currently 42.29% below its 52-week high of $333.00. Competitors Humana Inc. (HUM) and Centene Corp. (CNC) had mixed performances, with Humana rising 0.66% and Centene falling 1.08%. Trading volume was below the 50-day average.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Humana

Molina Healthcare Inc. Stock Underperforms Tuesday When Compared To Competitors

SPXV

Molina Healthcare Inc. (MOH) shares rose 1.47% to $195.53 on Monday, despite a declining stock market, with the S&P 500 down 0.41% and the Dow Jones down 1.13%. The stock's increase ended a two-day losing streak but remains 41.28% below its 52-week high of $333.00. Compared to competitors, Molina underperformed as Humana Inc. rose 1.85% and Centene Corp. rose 0.41%. Trading volume was significantly below the 50-day average.

Pro S&P 500 Ex-Hlth

Factset Research

Molina Healthcare Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Cwm LLC reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 95.4% in Q4, holding 3,522 shares valued at $611,000, according to its recent SEC filing. Other institutional investors also adjusted their positions, with Blue Trust Inc. increasing its stake by 23.8%. Molina Healthcare's stock opened at $194.79, with a market cap of $10.15 billion and a P/E ratio of 57.63. Analysts have mixed ratings on the stock, with target prices ranging from $129.00 to $220.00.

Cwm LLC Has $611,000 Stock Holdings in Molina Healthcare, Inc $MOH

Molina Healthcare Inc. (MOH) shares rose 3.48% to $185.46 on a challenging trading day for the market, marking its ninth consecutive day of gains. Despite this, the stock remains 44.31% below its 52-week high of $333.00. Competitors Humana Inc. (HUM) and Centene Corp. (CNC) also saw gains of 2.73% and 13.95%, respectively. Trading volume for Molina was 2.1 million, surpassing its 50-day average of 1.7 million.

Molina Healthcare Inc. Stock Outperforms Competitors On Strong Trading Day

Molina Healthcare shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

benzinga_article

Molina Healthcare (NYSE:MOH) reported quarterly earnings of $2.35 EPS, exceeding analysts' expectations of $2.16. The company generated $10.80 billion in revenue, slightly below the forecast of $10.91 billion. Molina's return on equity was 13.60% with a net margin of 1.04%. The stock rose 1.3% to $153.03, with a market cap of $7.97 billion. Analysts have mixed ratings, with an average target price of $169.21. Institutional investors hold 98.50% of the stock, which specializes in government-sponsored health insurance programs.

Invesco S&P 500 Equal Weight Health Care ETF(RSPH.US)